Future studies of APITD1 will be necessary to determine if it functions as a tumour suppressor gene upstream of TP53 and whether mutations in APITD1, although not commonly present in neuroblastoma, might be of importance in other tumour types. This evidence concerns the gene TP53 and neoplasm.